Researchers have been excited about the medication , a novel dual agonist showing promising data in clinical trials for size loss . It functions by impacting two pathways : GLP-1 and GIP, that , when https://phoebewdcs687086.popup-blog.com/39532774/a-new-possibility-for-size-management